Predict your next investment

Academic/University
BUSINESS PRODUCTS & SERVICES | Consulting & Outsourcing / Market, Industry & Competitive Research
rti.org

See what CB Insights has to offer

Investments

5

Portfolio Exits

3

Partners & Customers

10

Service Providers

1

About RTI International

Research Triangle Institute is an independent, nonprofit research institute which trades as RTI International. RTI International provides research & development and consulting to government, industry, academia, and public services clients globally.

RTI International Headquarter Location

3040 East Cornwallis Road P.O. Box 12194

Durham, North Carolina, 27709,

United States

919-541-6000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing RTI International

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find RTI International in 1 Expert Collection, including Conference Exhibitors.

C

Conference Exhibitors

5,302 items

RTI International Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

RTI International Rank

Latest RTI International News

U.S. vaccination effort against COVID-19 needs intensifying, warn researchers

Sep 23, 2021

Researchers have warned that the United States has not yet reached the necessary thresholds for achieving population immunity against severe acute respiratory coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19). The team – from RTI International in Research Triangle Park, North Carolina, and Pfizer Inc. in Collegeville, Pennsylvania – says that as of August 26th, 2021, not one state had achieved a level of population or “herd” immunity that would be considered sufficient to disrupt the transmission of the virus (78% or higher). Using publicly available data from the Centers for Disease Control and Prevention (CDC), the team calculated that the proportion of “presumed immunity,” acquired through vaccination or infection, varied substantially between states, from 43.1% to 70.6%. States with the highest levels of presumed immunity were those with the highest vaccination rates. In 19 states, at least 40% of people had neither been infected nor vaccinated and were presumed to have no immunity. While four states had reached presumed population immunity thresholds that would limit the transmission of less infectious SARS-CoV-2 variants (67%), none had reached the thresholds required for more infectious variants (78% or higher). After accounting for waning immunity, Marie Stoner and colleagues found that the presumed immunity might be even lower, resulting in a greater likelihood of sustained transmission in the United States. “As more infectious variants emerge, it is critical that vaccination efforts intensify across all states and ages for which the vaccines are approved,” says the team. A pre-print version of the research article is available on the medRxiv * server, while the paper undergoes peer review. More about population immunity thresholds Population or herd immunity occurs when a sufficient proportion of a community has become immune to a particular pathogen, making transmission from an infected person to susceptible individuals unlikely. The level of population immunity that is sufficient to limit the spread of a pathogen is usually calculated based on the reproductive number (R0) – a measure of how contagious a pathogen is. The estimated population immunity threshold for SARS-CoV2 has ranged from 50% to 83%, but it is likely to be even higher for more infectious variants that emerge. For, the B.1.617.2 (delta) variant that emerged in India in the spring of 2021, the estimated threshold is as high as 80% to 90%. The likelihood of reaching the population immunity threshold is influenced by the timing and patterns of transmission in different geographic areas. It is therefore essential to estimate the proportion of people in a given population that have “presumed immunity” as a result of vaccination or infection. Public health response efforts could then be focused on areas where the most significant impact can be achieved in terms of reducing the risk of severe COVID-19 and death. Related Stories What did the current study involve? Stoner and colleagues estimated the percentage of the US population with presumed immunity to SARS-CoV-2 as a result of vaccination, infection or both using publicly available data as of August 26th, 2021, from the CDC. Seroprevalence data were used to estimate the percentage of the population previously infected with SARS-CoV-2 and vaccination coverage data were used to calculate presumed immunity from vaccination. The estimates were compared to a range of thresholds considered necessary to achieve population-level immunity. A sensitivity analysis was also performed to account for waning immunity. What did the study find? As of August 26th, the percentage of the population with previous SARS-CoV-2 infection ranged from 4.0% in Hawaii to 41.7% in Mississippi and the percentage of vaccinated individuals ranged from 35.5% in Idaho to 61.5% in Massachusetts. The presumed population immunity ranged from 43.1% in Idaho to 70.6% in New Jersey. The states with the highest levels of presumed immunity were those with the highest vaccination rates. States with the lowest levels of presumed immunity had some of the lowest vaccination rates and in 19 states, at least 40% of the population had neither vaccine- nor infection-induced immunity. Percentage of the population vaccinated for COVID-19 and/or previously SARS-CoV-2 infected by state as of August 26, 2021 Using a minimum threshold (for less infectious variants) of 67% – corresponding to an R0 of 3 – only four states (New Jersey, Illinois, Maryland, Pennsylvania) would have reached population immunity. Based on a higher threshold for more infectious variants (78%; R0 of 4.5), none of the states would have reached population immunity. “Given that the threshold for the delta variant is likely even higher than 78%, we can assume that no states will have reached that threshold,” says the team. Furthermore, the sensitivity analysis assessing the effects of waning estimated that the level of presumed immunity would be even lower – ranging from 37.9% in Idaho to 62.3% in New Jersey – and that none of the states would meet even the minimum threshold of 67%. What do the researchers advise? Stoner and colleagues say that given the low levels of presumed immunity in many states and the possibility that more infectious variants may continue to emerge, it is imperative that vaccination efforts intensify within all states and that uptake occurs across all age groups as soon as vaccines are available. “Without increased population immunity, the risk of continued transmission and large outbreaks will exist throughout the US,” they warn. *Important Notice medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information. Journal reference: Stoner M, et al. Estimates of presumed population immunity to SARS-CoV-2 by state in the United States, August 2021, medRxiv, 2021. doi: https://doi.org/10.1101/2021.09.17.21263759 , https://www.medrxiv.org/content/10.1101/2021.09.17.21263759v1

RTI International Investments

5 Investments

RTI International has made 5 investments. Their latest investment was in PierianDx as part of their Series B - II on October 10, 2019.

CBI Logo

RTI International Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/28/2019

Series B - II

PierianDx

$27M

No

9

1/31/2019

Unattributed

Subscribe to see more

$99M

Subscribe to see more

10

2/12/2018

Series B

Subscribe to see more

$99M

Subscribe to see more

10

9/24/2009

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Unattributed

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/28/2019

1/31/2019

2/12/2018

9/24/2009

Round

Series B - II

Unattributed

Series B

Series B

Unattributed

Company

PierianDx

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$27M

$99M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

9

10

10

10

10

RTI International Portfolio Exits

3 Portfolio Exits

RTI International has 3 portfolio exits. Their latest portfolio exit was SPH Analytics on May 26, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/26/2021

Acquired

3

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

5/26/2021

00/00/0000

00/00/0000

Exit

Acquired

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

10

10

RTI International Acquisitions

6 Acquisitions

RTI International acquired 6 companies. Their latest acquisition was Medical Review Officers Certification Council on November 19, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/19/2018

Acquired

1

5/14/2018

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

3/27/2018

Seed

Subscribe to see more

$99M

Subscribe to see more

10

1/10/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

1/10/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/19/2018

5/14/2018

3/27/2018

1/10/2017

1/10/2017

Investment Stage

Acq - Fin

Seed

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

Total Funding

$99M

$99M

$99M

$99M

Note

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

RTI International Partners & Customers

10 Partners and customers

RTI International has 10 strategic partners and customers. RTI International recently partnered with U.S. News & World Report on April 4, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

4/27/2021

Partner

U.S. News & World Report

United States

U.S. News Unveils 2021 Best High Schools Rankings

For the seventh year in a row , U.S. News & World collaborated with RTI International , a leading nonprofit research institute , to research and produce the rankings .

1

3/16/2021

Partner

BroadReach

South Africa

RTI and BroadReach Group Partner for Impact

RESEARCH TRIANGLE PARK , N.C. -- Global health technology experts , the BroadReach Group , and nonprofit research institute , RTI International , are pleased to announce a partnership between the organizations .

1

1/27/2021

Partner

North Carolina Central University

United States

NCCU and RTI International Expand Partnership

The expansion of the partnership builds on an agreement between RTI International and North Carolina Central University established in April 2019 that has led to student internships and exchanges , curricula development , instrumentation and lab sharing , faculty and researcher contacts , as well as research partnerships with university faculty and RTI International investigators .

1

1/5/2021

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

11/5/2020

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

4/27/2021

3/16/2021

1/27/2021

1/5/2021

11/5/2020

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

U.S. News & World Report

BroadReach

North Carolina Central University

Country

United States

South Africa

United States

Subscribe to see more

Subscribe to see more

News Snippet

U.S. News Unveils 2021 Best High Schools Rankings

For the seventh year in a row , U.S. News & World collaborated with RTI International , a leading nonprofit research institute , to research and produce the rankings .

RTI and BroadReach Group Partner for Impact

RESEARCH TRIANGLE PARK , N.C. -- Global health technology experts , the BroadReach Group , and nonprofit research institute , RTI International , are pleased to announce a partnership between the organizations .

NCCU and RTI International Expand Partnership

The expansion of the partnership builds on an agreement between RTI International and North Carolina Central University established in April 2019 that has led to student internships and exchanges , curricula development , instrumentation and lab sharing , faculty and researcher contacts , as well as research partnerships with university faculty and RTI International investigators .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

RTI International Service Providers

1 Service Provider

RTI International has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Acquired

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

RTI International Team

4 Team Members

RTI International has 4 team members, including former Chief Financial Officer, Zvi Glasman.

Name

Work History

Title

Status

Zvi Glasman

Chief Financial Officer

Former

John Cavanagh

Senior Vice President

Former

David O Brien

Senior Vice President

Former

Daniel der Lelie

Senior Director

Former

Name

Zvi Glasman

John Cavanagh

David O Brien

Daniel der Lelie

Work History

Title

Chief Financial Officer

Senior Vice President

Senior Vice President

Senior Director

Status

Former

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.